Lundbeck Competitors and Similar CompaniesClear all

Lundbeck's competitors and similar companies include UCB, Care Solace, Odyssey Behavioral Healthcare and Neuro Vigor.

	Lundbeck H. Lundbeck is a pharmaceutical company specializing in brain diseases.	UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.	Care Solace Care Solace is a provider of mental health care coordination services.	Odyssey Behavioral Healthcare Odyssey Behavioral Healthcare is a company that provides behavioral healthcare services.	Neuro Vigor Neuro Vigor is a company that focuses on neurological diseases or injury to the central nervous system.
Founding Date	Founding Date 1915	Founding Date 1928	Founding Date 2015	Founding Date 2015	Founding Date 2013
Type	Type Public	Type Public	Type Private	Type Private	Type Private
Tags	Tags Healthcare medical diagnostics mental health pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare medical diagnostics mental health	Tags Healthcare medical diagnostics mental health	Tags Healthcare biotech drug development medical diagnostics mental health pharma
Locations	Locations København, DK HQ Buenos Aires, AR North Ryde, AU Wien, AT Bruxelles, BE Rio De Janeiro, BR Sofia, BG see more	Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more	Locations Encinitas, US HQ	Locations Brentwood, US HQ	Locations HQ
Employees	Employees 5,7072% decrease	Employees 9,0521% increase	Employees 2281% increase	Employees 1503% increase	Employees 3
Valuation ($)	Valuation ($) 6.2 b	Valuation ($) 34.3 b	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) kr22b (FY, 2024)	Revenue (est.) €5.6b (FY, 2024)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods kr2.5b (FY, 2024)	Cost of goods €1.1b (FY, 2024)	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit kr19.5b (FY, 2024)	Gross profit €6.2b (FY, 2024)	Gross profit N/A	Gross profit N/A	Gross profit N/A
Net income	Net income kr3.1b (FY, 2024)	Net income €1.1b (FY, 2024)	Net income N/A	Net income N/A	Net income N/A
Operating ⚠
Countries	Countries 100 (May, 2024)	Countries 35 (FY, 2019)	Countries N/A	Countries N/A	Countries N/A